PROCEPT BioRobotics Corporation (PRCT)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$17.83+$0.3346 (+1.91%) on the dayAs of the close; data may be delayed.
PRCT price, last 12 months
Key stats
- Previous close
- $17.50
- Open
- $17.30
- Day range
- $17.05 – $17.86
- 52-week range
- $16.67 – $38.11
- Volume
- 1.8M
- Avg volume (20 days)
- 1.3M
- Market cap
- $985.1M
Performance
1W−7.6%
1M−15.4%
3M−21.0%
6M−28.9%
YTD−43.3%
1Y−52.6%
vs S&P 500, 1Y−69.4 pts
Technicals and fundamentals
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $985.1M